nandrolone has been researched along with estradiol valerate-dienogest in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (23.26) | 29.6817 |
| 2010's | 33 (76.74) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perry, CM; Wellington, K | 1 |
| Anderer, P; Gräser, T; Gruber, D; Huber, J; Metka, M; Oettel, M; Saletu, B; Saletu-Zyhlarz, G; Semlitsch, HV | 1 |
| Carlström, K; Conner, P; Gräser, T; Skoog, L; Söderqvist, G; Tani, E; von Schoultz, B; Walter, F | 1 |
| Abu-Bakr, MH; Anderer, P; Gräser, T; Grätzhofer, E; Gruber, D; Gruber, G; Huber, J; Mandl, M; Metka, M; Oettel, M; Saletu, B; Saletu-Zyhlarz, G | 1 |
| Teichmann, A | 1 |
| von Schoultz, B | 1 |
| Anderer, P; Gruber, D; Huber, J; Metka, M; Pascual-Marqui, RD; Saletu, B; Saletu-Zyhlarz, G | 1 |
| Anderer, P; Gruber, D; Huber, J; Metka, M; Saletu, B; Saletu-Zyhlarz, GM | 1 |
| Godekmerdan, A; Gurates, B; Kumru, S; Kutlu, S; Yildiz, FM; Yilmaz, B | 1 |
| Ahrendt, HJ; Makalová, D; Mansour, D; Mellinger, U; Parke, S | 1 |
| Jensen, JT | 1 |
| Gaspard, U; Kridelka, F; Pintiaux, A | 1 |
| Azizi-Malekabadi, H; Hosseini, M; Karami, R; Khodabandehloo, F; Saffarzadeh, F | 1 |
| Junge, W; Mellinger, U; Parke, S; Serrani, M | 1 |
| Agnello, C; Caruso, S; Cianci, A; Cianci, S; Lo Presti, L; Malandrino, C; Romano, M | 1 |
| Rose, R; Whalen, KL | 1 |
| Borgelt, LM; Martell, CW | 1 |
| Fraser, IS; Jensen, J; Mellinger, U; Parke, S; Schaefers, M; Serrani, M | 1 |
| Blode, H; Kunz, M; Mellinger, U; Parke, S; Rohde, B; Zeun, S; Zimmermann, T | 1 |
| Bifulco, G; De Rosa, N; Di Carlo, C; Di Spiezio Sardo, A; Greco, E; Nappi, C; Spinelli, M; Tommaselli, GA | 1 |
| Jensen, JT; Micks, EA | 1 |
| Fraser, IS; Junge, W; Parke, S; Serrani, M; Wilke, B; Zeun, S | 1 |
| Martini, E; Nappi, RE; Sances, G; Santamaria, V; Spinillo, A; Tassorelli, C; Terreno, E; Tonani, S | 1 |
| Mocciaro, R; Morelli, M; Sacchinelli, A; Venturella, R; Zullo, F | 1 |
| Filonenko, A; Jeddi, M; Jensen, JT; Law, A; Siak, S; Stull, DE; Vanness, DJ; Wasiak, R; Wittrup-Jensen, KU | 1 |
| Jensen, JT; Mabey, RG; Mellinger, U; Parke, S; Serrani, M | 1 |
| Makalova, D; Mellinger, U; Nelson, A; Palacios, S; Parke, S; Serrani, M | 1 |
| De Leo, V; Di Sabatino, A; Fruzzetti, F; Morgante, G; Musacchio, MC; Scolaro, V | 1 |
| Mellinger, U; Nelson, A; Parke, S; Schmidt, A; Zampaglione, E | 1 |
| Shulman, LP | 1 |
| Mellinger, U; Parke, S; Petraglia, F; Römer, T; Serrani, M | 1 |
| Banco, R; Barbati, G; Conversano, E; De Leo, R; De Seta, F; Lello, S; Maso, G; Restaino, S; Tonon, M | 1 |
| Graziottin, A | 2 |
| Cagnacci, A; Grandi, G; Napolitano, A; Palma, F; Xholli, A | 1 |
| Calaf, J; Canals, I; Crespo, C; Cristóbal, I; Espinós, B; Lete, I | 1 |
| Calagna, G; Colacurci, N; Cucinella, G; De Franciscis, P; Granese, R; Perino, A; Saitta, S; Triolo, O | 1 |
| Chabbert-Buffet, N; Jamin, C; Lello, S; Lete, I; Lobo, P; Nappi, RE; Pintiaux, A | 1 |
| Dietrich, H; Mittmann, K; Rouskova, D; Schumacher, U; Zimmermann, T | 1 |
| Cagnacci, A; D'Alterio, MN; Di Carlo, C; Lello, S; Malune, ME; Melis, GB; Motzo, C; Neri, M; Orrù, M; Paoletti, AM; Pilloni, M; Zedda, P | 1 |
| Barnett, C; Dinger, J; Do Minh, T; Hagemann, C; Heinemann, K | 1 |
| Akkaya, H; Cagli, F; Tayyar, AT; Tutus, S; Uysal, G | 1 |
| Jaisamrarn, U; Lu, D; Parke, S; Suturina, L; Yu, Q; Zhou, Y | 1 |
11 review(s) available for nandrolone and estradiol valerate-dienogest
| Article | Year |
|---|---|
Estradiol valerate/dienogest.
Topics: Administration, Oral; Animals; Bone Density; Clinical Trials as Topic; Drug Combinations; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; In Vitro Techniques; Middle Aged; Nandrolone; Osteoporosis, Postmenopausal; Postmenopause | 2002 |
Pharmacology of estradiol valerate/dienogest.
Topics: Drug Administration Schedule; Drug Combinations; Endometrium; Estradiol; Female; Humans; Nandrolone | 2003 |
Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
Topics: Clinical Trials as Topic; Drug Combinations; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Nandrolone; Uterine Hemorrhage | 2003 |
Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Combinations; Drug Design; Estradiol; Female; Humans; Menorrhagia; Nandrolone; Pregnancy; Pregnancy, Unplanned; Young Adult | 2010 |
Estradiol valerate/dienogest: a novel oral contraceptive.
Topics: Clinical Trials as Topic; Contraceptives, Oral; Drug Combinations; Drug Costs; Estradiol; Female; Humans; Nandrolone | 2011 |
Estradiol valerate/dienogest: a novel combined oral contraceptive.
Topics: Administration, Oral; Animals; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Drug Combinations; Drug Costs; Estradiol; Female; Humans; Nandrolone; Pregnancy; Treatment Outcome | 2012 |
Treatment of heavy menstrual bleeding with the estradiol valerate and dienogest oral contraceptive pill.
Topics: Contraceptives, Oral; Drug Combinations; Estradiol; Female; Humans; Menorrhagia; Nandrolone | 2013 |
Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe.
Topics: Adolescent; Adult; Clinical Trials, Phase III as Topic; Contraception; Contraceptives, Oral; Drug Combinations; Estradiol; Europe; Female; Humans; Menstruation; Metrorrhagia; Middle Aged; Nandrolone; North America; Treatment Outcome; Young Adult | 2013 |
Contraception containing estradiol valerate and dienogest--advantages, adherence and user satisfaction.
Topics: Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Medication Adherence; Nandrolone; Patient Satisfaction; Quality of Life; Reproducibility of Results | 2014 |
Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Topics: Androstenes; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Lipid Metabolism; Megestrol; Nandrolone; Venous Thromboembolism | 2015 |
The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Drug Combinations; Dysmenorrhea; Estradiol; Estrogens; Female; Gastrointestinal Diseases; Headache; Humans; Inflammation; Menstruation; Mood Disorders; Nandrolone; Pelvic Pain; Progesterone; Quality of Life | 2016 |
18 trial(s) available for nandrolone and estradiol valerate-dienogest
| Article | Year |
|---|---|
Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia.
Topics: Affect; Aged; Double-Blind Method; Drug Combinations; Electrophysiology; Estradiol; Event-Related Potentials, P300; Evoked Potentials, Auditory; Female; Hormone Replacement Therapy; Humans; Middle Aged; Nandrolone; Neuropsychological Tests; Postmenopause; Progesterone Congeners; Reaction Time; Sleep Initiation and Maintenance Disorders | 2003 |
Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology.
Topics: Biopsy, Needle; Breast; Cell Division; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrone; Female; Humans; Ki-67 Antigen; Middle Aged; Nandrolone; Norethindrone; Postmenopause; Prospective Studies | 2003 |
Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen
Topics: Aged; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Memory; Middle Aged; Nandrolone; Polysomnography; Postmenopause; Reaction Time; Severity of Illness Index; Sleep Apnea Syndromes; Sleep Initiation and Maintenance Disorders; Sleep, REM; Wakefulness | 2003 |
Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials.
Topics: Acoustic Stimulation; Aged; Brain; Brain Mapping; Case-Control Studies; Cross-Over Studies; Discrimination Learning; Dose-Response Relationship, Radiation; Double-Blind Method; Drug Combinations; Electroencephalography; Estradiol; Estrogen Replacement Therapy; Evoked Potentials, Auditory; Female; Humans; Male; Middle Aged; Nandrolone; Postmenopause; Reaction Time; Sleep Initiation and Maintenance Disorders; Tomography | 2004 |
Identifying target regions for vigilance improvement under hormone replacement therapy in postmenopausal syndrome patients by means of electroencephalographic tomography (LORETA).
Topics: Arousal; Brain Mapping; Data Interpretation, Statistical; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Electroencephalography; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nandrolone; Patient Selection; Sleep Initiation and Maintenance Disorders; Tablets | 2005 |
Effects of raloxifene and hormone replacement therapy on serum Th2 and Th3 type cytokine concentrations in healthy postmenopausal women: a randomised controlled trial.
Topics: Bone Density Conservation Agents; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Interleukin-4; Middle Aged; Nandrolone; Postmenopause; Raloxifene Hydrochloride; Single-Blind Method; T-Lymphocytes, Regulatory; Th2 Cells; Transforming Growth Factor beta1 | 2008 |
Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Metrorrhagia; Middle Aged; Nandrolone; Patient Satisfaction; Treatment Outcome; Young Adult | 2009 |
Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
Topics: Adult; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Glucose Tolerance Test; Hematologic Tests; Hemostasis; Humans; Levonorgestrel; Lipids; Middle Aged; Nandrolone; Thyroid Function Tests; Treatment Outcome; Young Adult | 2011 |
Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Drug Combinations; Estradiol; Female; Humans; Middle Aged; Nandrolone; Quality of Life; Sex Hormone-Binding Globulin; Sexual Behavior; Surveys and Questionnaires; Testosterone; Time Factors; Young Adult | 2011 |
Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women.
Topics: Aged; Anti-Infective Agents; Biotransformation; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Combinations; Drug Interactions; Enzyme Induction; Erythromycin; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Humans; Ketoconazole; Middle Aged; Nandrolone; Postmenopause; Rifampin | 2012 |
Improving the objective quality of large-scale clinical trials for women with heavy menstrual bleeding: experience from 2 multi-center, randomized trials.
Topics: Contraceptives, Oral; Double-Blind Method; Drug Combinations; Estradiol; Female; Follow-Up Studies; Humans; Internationality; Menorrhagia; Nandrolone | 2013 |
Impact of estradiol valerate/dienogest on work productivity and activities of daily living in women with heavy menstrual bleeding.
Topics: Activities of Daily Living; Adult; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Combinations; Efficiency; Estradiol; Female; Humans; Menorrhagia; Middle Aged; Nandrolone; Treatment Outcome; Work; Young Adult | 2013 |
Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.
Topics: Adult; Contraceptives, Oral; Double-Blind Method; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Headache; Humans; Menstruation; Nandrolone; Norgestrel; Pelvic Pain; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2013 |
Efficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: results from a clinical study conducted in North America.
Topics: Adolescent; Adult; Canada; Contraception; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Humans; Menstrual Cycle; Nandrolone; Ovulation Inhibition; Pregnancy; Treatment Outcome; United States; Young Adult | 2014 |
Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
Topics: Adolescent; Adult; Double-Blind Method; Drug Combinations; Dysmenorrhea; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Nandrolone; Time Factors; Treatment Outcome; Young Adult | 2014 |
Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi-center randomized trial.
Topics: Adolescent; Adult; Drug Combinations; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Italy; Laparoscopy; Middle Aged; Nandrolone; Pain Management; Pain Measurement; Pelvic Pain; Prospective Studies; Quality of Life; Recurrence; Surveys and Questionnaires | 2015 |
A comparison of two different oral contraceptives in patients with severe primary dysmenorrhoea.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral; Drug Combinations; Dysmenorrhea; Estradiol; Ethinyl Estradiol; Female; Humans; Nandrolone; Pain Measurement; Pelvic Pain; Prospective Studies; Pulsatile Flow; Treatment Outcome; Ultrasonography, Doppler; Uterine Artery; Young Adult | 2018 |
Efficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial.
Topics: Adult; Contraceptives, Oral; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Ferritins; Hemoglobins; Humans; Menorrhagia; Menstrual Cycle; Nandrolone; Treatment Outcome | 2018 |
14 other study(ies) available for nandrolone and estradiol valerate-dienogest
| Article | Year |
|---|---|
[Medication of the month. A new combined oral contraceptive containing estradiol valerate and dienogest (Qlaira)].
Topics: Clinical Trials as Topic; Contraceptives, Oral; Drug Combinations; Estradiol; Female; Humans; Nandrolone | 2010 |
Chronic treatment with the nitric oxide synthase inhibitor, L-NAME, attenuates estradiol-mediated improvement of learning and memory in ovariectomized rats.
Topics: Animals; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens; Female; Maze Learning; Memory; Models, Animal; Nandrolone; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ovariectomy; Random Allocation; Rats; Rats, Wistar; Reaction Time; Spatial Behavior | 2011 |
Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest.
Topics: Adolescent; Adult; Androgens; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Combinations; Estradiol; Estrogens; Female; Humans; Intention to Treat Analysis; Menorrhagia; Middle Aged; Nandrolone; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2012 |
The use of an oral contraceptive containing estradiol valerate and dienogest before office operative hysteroscopy: a feasibility study.
Topics: Adult; Case-Control Studies; Contraceptives, Oral, Combined; Drug Combinations; Endometrial Neoplasms; Endometrium; Estradiol; Feasibility Studies; Female; Hospitals, University; Humans; Hysteroscopy; Nandrolone; Operative Time; Outpatient Clinics, Hospital; Pain, Postoperative; Pilot Projects; Polyps; Preoperative Care; Prospective Studies; Sterilization, Tubal; Uterus | 2012 |
Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Topics: Adult; Analgesics; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Dysmenorrhea; Estradiol; Female; Humans; Italy; Menstruation; Migraine Disorders; Nandrolone; Pilot Projects; Prospective Studies; Treatment Outcome | 2013 |
Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
Topics: Adult; Combined Modality Therapy; Contraceptive Agents, Female; Drug Combinations; Endometriosis; Estradiol; Estrogens; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Nandrolone; Patient Satisfaction; Pelvic Pain; Postoperative Care; Receptors, Progesterone; Retrospective Studies; Secondary Prevention | 2013 |
Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.
Topics: Adolescent; Adult; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Italy; Nandrolone; Overweight; Polycystic Ovary Syndrome; Young Adult | 2013 |
The best prophet of the future is the past: oral contraception and novel components.
Topics: Contraception; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Nandrolone; Ovulation Inhibition; Pregnancy | 2014 |
Effects of estroprogestins containing natural estrogen on vaginal flora.
Topics: Adolescent; Adult; Drug Combinations; Estradiol; Female; Humans; Megestrol; Middle Aged; Nandrolone; Norpregnadienes; Prospective Studies; Vagina; Young Adult | 2014 |
Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
Topics: Adult; Contraceptives, Oral, Hormonal; Drug Combinations; Dysmenorrhea; Endometriosis; Estradiol; Female; Hospitals, University; Humans; Italy; Nandrolone; Pain Measurement; Patient Preference; Pelvic Pain; Pilot Projects; Prospective Studies; Quality of Life; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2015 |
Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain.
Topics: Contraceptives, Oral, Combined; Cost-Benefit Analysis; Drug Combinations; Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Models, Theoretical; Nandrolone; Spain | 2015 |
Effectiveness, tolerability and acceptance of a low-dosed estradiol/dienogest formulation (Lafamme 1 mg/2 mg) for the treatment of menopausal complaints: a non-interventional observational study over 6 cycles of 28 days.
Topics: Androgens; Drug Combinations; Estradiol; Estrogens; Female; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Nandrolone; Outcome Assessment, Health Care; Patient Outcome Assessment | 2015 |
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation.
Topics: Adipose Tissue; Adult; Body Composition; Body Mass Index; Body Water; Body Weight; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Menopause; Middle Aged; Nandrolone; Prospective Studies; Waist-Hip Ratio | 2016 |
Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Europe; Female; Fertility; Follow-Up Studies; Humans; Levonorgestrel; Medication Adherence; Nandrolone; Pregnancy; Pregnancy Rate; Pregnancy, Unplanned; Prospective Studies; United States; Withholding Treatment; Young Adult | 2017 |